Loading... Please wait... Loading... Please wait...
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
|---|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | $4.55 | $320.64 M | -1.97 | 145 | $20.76 M | ||
| Alpha Tau Medical Ltd. | $2.23 | $170.30 M | -5.95 | 121 | $0 | ||
| Design Therapeutics, Inc. | $3.19 | $217.51 M | -3.7 | 57 | $0 | ||
| ESSA Pharma Inc. | $4.78 | $253.76 M | -9.08 | 50 | $0 | ||
| Erasca, Inc. | $2.18 | $647.94 M | -2.83 | 126 | $0 | ||
| Edgewise Therapeutics, Inc. | $18.28 | $1.65 B | -11.47 | 92 | $0 | ||
| Eyenovia, Inc. | $0.77 | $40.94 M | -1.03 | 57 | $3,787 | ||
| Generation Bio Co. | $2.44 | $216.88 M | -1.28 | 174 | $5.90 M | ||
| Monte Rosa Therapeutics, Inc. | $3.89 | $243.38 M | -1.59 | 130 | $0 | ||
| Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 | ||
| Graphite Bio, Inc. | $3.18 | $185.19 M | -0.21 | 6 | $0 | ||
| Inhibrx, Inc. | $13.44 | $241.02 M | -1.44 | 166 | $1.80 M | ||
| Inozyme Pharma, Inc. | $4.49 | $286.39 M | -3.43 | 59 | $0 | ||
| Kronos Bio, Inc. | $1.13 | $44.62 M | -0.37 | 61 | $6.29 M | ||
| Lyra Therapeutics, Inc. | $0.28 | $19.53 M | -0.27 | 109 | $1.56 M | ||
| Merrimack Pharmaceuticals, Inc. | $15.15 | $223.75 M | -168.11 | 0 | $0 | ||
| Nuvation Bio Inc. | $2.94 | $684.66 M | -8.66 | 159 | $0 | ||
| NextCure, Inc. | $1.57 | $38.88 M | -0.61 | 82 | $0 | ||
| Ocular Therapeutix, Inc. | $6.69 | $765.15 M | -4.41 | 267 | $58.44 M | ||
| ORIC Pharmaceuticals, Inc. | $7.52 | $595.34 M | -4.91 | 102 | $0 | ||
| POINT Biopharma Global Inc. | $12.50 | $1.33 B | 11.36 | 129 | $226.58 M | ||
| Sensei Biotherapeutics, Inc. | $0.62 | $16.31 M | -0.54 | 27 | $0 | ||
| Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 | ||
| Tenaya Therapeutics, Inc. | $2.91 | $285.80 M | -2.21 | 140 | $0 |
